Home › Categories › Business & Finance› ニプロ、ジェ� �リック医薬品� ��造・販売の田辺製薬販売を� �収

ニプロ、ジェ� �リック医薬品� ��造・販売の田辺製薬販売を� �収.pdf

170328.pdf

Preview of ニプロ、ジェ� �リック医薬品� ��造・販売の田辺製薬販売を� �収

🔗 Source: nipro.co.jp

📊 Size: 119 KB

📄 Pages: 2 pages

⬇️ Downloads: 108

Summary

Nipro Corporation has entered into a share transfer agreement to acquire all issued shares of Tanabe Pharmaceutical Sales Co., Ltd., a wholly-owned subsidiary of Tanabe Mitsubishi Pharmaceutical Co., Ltd., making it a subsidiary. The acquisition aims to strengthen Nipro's generic drug business by expanding its product lineup, enhancing its brand, and strengthening its sales network. The acquired company has 51 generic drug products, 26 long-listed products, and 1 authorized generic product. The acquisition is expected to have no impact on Nipro's current fiscal year performance.

Download File

Description

Nipro Corporation has entered into a share transfer agreement to acquire all issued shares of Tanabe Pharmaceutical Sales Co., Ltd., a wholly-owned subsidiary...

Technical Information

File Format: PDF
File Size: 119 KB
Pages: 2
Language: EN
Total Downloads: 108
Last Updated: 1 month ago

Document Overview

This PDF document about ニプロ、ジェ� �リック医薬品� ��造・販売の田辺製薬販売を� �収 provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into ニプロ、ジェ� �リック医薬品� ��造・販売の田辺製薬販売を� �収.